Alliance Personalized Oncology Care

    The Colorectal Cancer Alliance provides personalized support and expert guidance for patients and families at every stage of the colorectal cancer experience —from diagnosis and treatment to clinical trials, survivorship, and end-of-life care

    Let's get started

    After completing the questions below, you will be contacted within 2 business days from our clinical navigation team.

     

    Alliance Personalized Oncology Care Application

    MM/DD/YYYY
    select non-US if outside of the US
    MM/DD/YYYY
    MM/DD/YYYY

    Contact Information

    Top resources

    View all resources
    A close-up digital illustration of glowing blue DNA strands twisting through a dark blue background. Multiple double helixes appear at different depths, connected by a network of lighted nodes and lines.

    A blood test that sees what scans can't

    For many cancer patients, the end of active treatment brings a new kind of dread. Scans every few months and anxious waits for results. A blood test is changing that experience for a growing number of patients.

    Last updated
    A collage featuring a smiling woman with a chest infusion port, a medical team preparing for a procedure, and a close-up of an HAI pump used for liver-directed chemotherapy treatment.

    HAI therapy proves pivotal for pioneering patient

    When Helen was diagnosed with metastatic colorectal cancer, the biggest concern for her medical team was that her cancer had spread to her liver. One type of therapy, hepatic artery infusion, offered a path forward, but there was a catch. Nobody at her hospital had ever done it before. She'd have to be first.

    Last updated
    Dr. Mielke smiles while working in a research laboratory, wearing a white lab coat and blue gloves as she holds a pipette beside lab equipment.

    Where breakthroughs begin: Project Cure CRC spotlight on Dr. Lisa Mielke

    hrough Project Cure CRC, the Alliance is fueling bold, early-stage research with the potential to transform colorectal cancer treatment. Dr. Lisa Mielke’s groundbreaking work explores how the gut’s immune system and nerve signaling influence cancer growth—opening the door to new therapeutic approaches, including repurposed existing drugs. This is what’s possible when promising ideas get the support they need to move forward.

    Last updated